AngioDynamics Inc. has acquired substantially all the assets of FlowMedica Inc., a Fremont, Calif.-based provider of targeted renal therapy solutions. The deal is valued at $1.75 million in cash, plus a possible earnout based on 2011 sales of a FlowMedica product. FlowMedica had raised over $28 million in VC funding since 2002, from Oxford Bioscience Partners, De Novo Ventures, Mi3 Venture Partners, Medica Venture Partners and Palo Alto Investors.
